Haemonetics (HAE) Other Non-Current Assets (2016 - 2025)
Haemonetics has reported Other Non-Current Assets over the past 16 years, most recently at $216.1 million for Q4 2025.
- Quarterly results put Other Non-Current Assets at $216.1 million for Q4 2025, up 34.71% from a year ago — trailing twelve months through Dec 2025 was $216.1 million (up 34.71% YoY), and the annual figure for FY2025 was $164.1 million, up 20.32%.
- Other Non-Current Assets for Q4 2025 was $216.1 million at Haemonetics, up from $208.0 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for HAE hit a ceiling of $216.1 million in Q4 2025 and a floor of $63.2 million in Q2 2022.
- Median Other Non-Current Assets over the past 5 years was $117.2 million (2023), compared with a mean of $121.8 million.
- Biggest five-year swings in Other Non-Current Assets: fell 10.83% in 2022 and later skyrocketed 69.25% in 2023.
- Haemonetics' Other Non-Current Assets stood at $66.6 million in 2021, then skyrocketed by 55.08% to $103.3 million in 2022, then increased by 23.39% to $127.4 million in 2023, then rose by 25.87% to $160.4 million in 2024, then soared by 34.71% to $216.1 million in 2025.
- The last three reported values for Other Non-Current Assets were $216.1 million (Q4 2025), $208.0 million (Q3 2025), and $196.3 million (Q2 2025) per Business Quant data.